Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors

Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors

Mycosis fungoides (MF) and Sézary syndrome (SS) are forms of cutaneous T cell lymphoma (CTCL) that pose significant challenges in their clinical management, particularly in refractory and advanced-stage disease. With the emergence of novel therapeutic modalities however, there are increasing opportu...

Full description

Bibliographic Details
Main Authors: Iman Quadri, John C. Reneau, Walter Hanel, Catherine G. Chung
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Immunology
Subjects:
cutaneous T-cell lymphoma
mycosis fungoides
Sézary syndrome
immunotherapy
immune checkpoint inhibitors
cancer therapeutics
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1291259/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1291259/full

Similar Items